Fundz

Bio Medomics, Inc. reported raising $530,000 in an initial SEC Form D filing, from an offering of $2.73 Million

PRIVATEJul 28, 2017$530K of $2.7M raised

Amount Raised

$530,000

$530,000 sold, per SEC Form D (first sale Jul 28, 2017)

Round Type

Seed

Research Triangle ParkBiotechnology

Quick answer

BioMedomics, Inc. raised $530,000 in a Seed round, dated July 28, 2017. BioMedomics, Inc. is based in Research Triangle Park, North Carolina, United States.

How much did BioMedomics, Inc. raise?
BioMedomics, Inc. raised $530,000 in a Seed round on July 28, 2017.
What does BioMedomics, Inc. do?
BioMedomics is a point-of-care diagnostics company that aims to provide novel, rapid point-of-care tests to aid in the diagnosis of critical diseases.
Where is BioMedomics, Inc. based and how big is it?
BioMedomics, Inc. is based in Research Triangle Park, North Carolina, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as BioMedomics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • NeuroGeneCES LLC raised an undisclosed amount on September 11, 2017.
  • Antidote Therapeutics, Inc. raised $200K (Seed) on September 11, 2017.
  • Kineta, Inc. raised $5M on September 11, 2017.
  • Aqueduct Critical Care, Inc. raised $640K (Seed) on September 7, 2017.
  • Excelitas raised $300K (Seed) on September 7, 2017.
  • Liquid Biosciences raised $40M on September 7, 2017.

Who to call at BioMedomics, Inc., and when

A new round usually means BioMedomics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioMedomics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioMedomics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioMedomics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioMedomics, Inc.

Location

6 DAVIS DRIVE

Research Triangle Park, North Carolina, United States

About

BioMedomics is a point-of-care diagnostics company that aims to provide novel, rapid point-of-care tests to aid in the diagnosis of critical diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioMedomics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for BioMedomics, Inc.'s next move

See what Strategic adds

BioMedomics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.